R. Torguson

发表

Impact of sex on long‐term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes

Samin K. Sharma, G. Dangas, R. Mehran, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Optimizing Monotherapy Selection, Aspirin Versus P2Y12 Inhibitors, Following Percutaneous Coronary Intervention.

Brian C. Case, W. Weintraub, R. Torguson, 2020, The American journal of cardiology.

Intravascular ultrasound lumen area parameters for assessment of physiological ischemia by fractional flow reserve in intermediate coronary artery stenosis.

A. Pichard, L. Satler, R. Torguson, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Management and Outcome of Residual Aortic Regurgitation After Transcatheter Aortic Valve Implantation.

A. Pichard, L. Satler, A. Steinvil, 2017, American Journal of Cardiology.

Relation of preprocedural assessment of myocardial contractility reserve on outcomes of aortic stenosis patients with impaired left ventricular function undergoing transcatheter aortic valve implantation.

I. Barbash, D. Dvir, A. Pichard, 2014, The American journal of cardiology.

Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies.

I. Barbash, D. Dvir, A. Pichard, 2013, Cardiovascular Revascularization Medicine.

Effects of percutaneous aortic valve replacement on coronary blood flow assessed with transesophageal Doppler echocardiography in patients with severe aortic stenosis.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Impact of restrictive versus obstructive pulmonary function patterns on mortality in patients undergoing transcatheter aortic valve implantation.

A. Pichard, L. Satler, R. Torguson, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Coronary blood flow in patients with severe aortic stenosis before and after transcatheter aortic valve implantation.

A. Pichard, L. Satler, S. Goldstein, 2014, The American journal of cardiology.

Valvular and Congenital Heart Disease Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement

I. Barbash, D. Dvir, A. Pichard, 2012 .

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement.

I. Barbash, D. Dvir, A. Pichard, 2012, American heart journal.

Stent thrombosis is not increased following percutaneous coronary intervention in patients with non-insulin dependent diabetes mellitus taking metformin.

R. Torguson, R. Waksman, M. Lipinski, 2014, Atherosclerosis.

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy

Patrick W Serruys, Evelyn Regar, Ron Waksman, 2004, The Lancet.

Effect of insurance type on adverse cardiac events after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, American Journal of Cardiology.

Insurance type influences the use of drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, JACC. Cardiovascular interventions.

Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, Journal of interventional cardiology.

Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three‐vessel coronary artery disease

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Frequency of conduction disturbances after transcatheter implantation of an Edwards SAPIEN aortic valve prosthesis

I. Barbash, D. Dvir, A. Pichard, 2012 .

A First-inMan , Randomized , Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

P. Fitzgerald, N. Weissman, H. Brewer, 2022 .

Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis.

S. Epstein, K. Kent, A. Pichard, 2011, The American journal of cardiology.

Repeat Intracoronary Radiation for Recurrent In-Stent Restenosis in Patients Who Failed Intracoronary Radiation

K. Kent, A. Pichard, L. Satler, 2003, Circulation.

Intracoronary Radiation Therapy Improves the Clinical and Angiographic Outcomes of Diffuse In-Stent Restenotic Lesions: Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies

P. Teirstein, K. Kent, A. Pichard, 2003, Circulation.

Clinical outcomes of first- and second-generation drug-eluting stents in patients undergoing rotational atherectomy for heavily calcified coronary lesions.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drugeluting stent era.

A. Pichard, L. Satler, R. Torguson, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3-Stent Generations

A. Pichard, L. Satler, R. Torguson, 2014, Circulation. Cardiovascular interventions.

Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients.

M. Buchbinder, C. Zhang, T. Bilfinger, 2021, Circulation. Cardiovascular interventions.

Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial.

M. Buchbinder, T. Bilfinger, L. Satler, 2021, American heart journal.

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis.

T. Bilfinger, L. Satler, F. Asch, 2020, JACC. Cardiovascular interventions.

Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement.

M. Buchbinder, T. Bilfinger, L. Satler, 2019, Circulation. Cardiovascular imaging.

TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial.

M. Buchbinder, T. Bilfinger, L. Satler, 2019, JACC. Cardiovascular interventions.

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.

T. Bilfinger, L. Satler, F. Asch, 2018, Journal of the American College of Cardiology.

Ischemic Versus Bleeding Outcomes After Percutaneous Coronary Interventions in Patients With High Bleeding Risk.

W. Weintraub, L. Satler, R. Torguson, 2020, The American journal of cardiology.

Genetic and Nongenetic Implications of Racial Variation in Response to Antiplatelet Therapy.

S. Attaran, W. Weintraub, R. Torguson, 2019, The American journal of cardiology.

Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial.

R. Torguson, Charan T. Yerasi, R. Waksman, 2015, Journal of the American Society of Hypertension : JASH.

Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital.

A. Pichard, R. Torguson, R. Waksman, 2017, American Journal of Cardiology.

Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel disease.

K. Kent, A. Pichard, L. Satler, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI - State-of-the-art review.

A. Pichard, L. Satler, R. Torguson, 2018, International journal of cardiology.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Outcome of implantation of a second self‐expanding valve for the treatment of residual significant aortic regurgitation

A. Pichard, L. Satler, R. Torguson, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Does the disparity in baseline characteristics of patients undergoing transcatheter aortic valve replacement with 23 mm vs. 26 mm valves impact clinical outcome?

A. Pichard, L. Satler, R. Torguson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of clinical outcomes with the utilization of monitored anesthesia care vs. general anesthesia in patients undergoing transcatheter aortic valve replacement.

A. Pichard, L. Satler, F. Asch, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

I. Barbash, D. Dvir, A. Pichard, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The impact of prior stroke on the outcome of patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

A. Pichard, R. Torguson, R. Waksman, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Intravascular ultrasound lumen area parameters for assessment of physiological ischemia by fractional flow reserve in intermediate coronary artery stenosis.

A. Pichard, L. Satler, R. Torguson, 2012, Cardiovascular revascularization medicine : including molecular interventions.

The state of the excimer laser for coronary intervention in the drug-eluting stent era.

I. Barbash, D. Dvir, A. Pichard, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.

W. Weintraub, A. Pichard, L. Satler, 2018, The American journal of cardiology.

Effect of Bleeding Risk on Type of Stent Used in Patients Presenting With Acute Coronary Syndrome.

A. Pichard, L. Satler, A. Steinvil, 2017, The American journal of cardiology.

The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.

S. Silber, P. Stella, G. Sangiorgi, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database

R. Torguson, R. Waksman, Toby Rogers, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions

A. Pichard, L. Satler, R. Torguson, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A propensity score matched analysis to determine if second-generation drug-eluting stents outperform first-generation drug-eluting stents in a complex patient population.

A. Pichard, L. Satler, R. Torguson, 2013, International journal of cardiology.

Comparison of adverse outcomes after contemporary percutaneous coronary intervention in women versus men with acute coronary syndrome.

I. Barbash, D. Dvir, A. Pichard, 2013, The American journal of cardiology.

Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables.

A. Pichard, R. Torguson, R. Waksman, 2016, American Heart Journal.

Analysis of long-term survival following transcatheter aortic valve implantation from a single high-volume center.

A. Pichard, L. Satler, R. Torguson, 2015, The American journal of cardiology.

Vascular access in critical limb ischemia.

R. Torguson, R. Waksman, M. Lipinski, 2016, Cardiovascular revascularization medicine : including molecular interventions.

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis.

H. Brewer, R. Torguson, R. Waksman, 2016, European heart journal.

Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.

K. Kent, A. Pichard, L. Satler, 2009, Cardiovascular revascularization medicine : including molecular interventions.

NIRS-IVUS: One Imaging System May Fit All.

R. Torguson, R. Waksman, R. Waksman, 2020, JACC. Cardiovascular imaging.

Response to letter regarding article, "Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations".

A. Pichard, L. Satler, R. Torguson, 2015, Circulation. Cardiovascular interventions.

Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations.

L. Satler, R. Torguson, R. Waksman, 2014, American heart journal.

Red cell distribution width as a bleeding predictor after percutaneous coronary intervention.

A. Pichard, L. Satler, N. Kleiman, 2013, American Heart Journal.

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).

S. Mehta, D. Dvir, R. Torguson, 2013, Journal of interventional cardiology.

Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation.

K. Kent, A. Pichard, L. Satler, 2011, The American journal of cardiology.

Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy.

K. Kent, A. Pichard, L. Satler, 2010, Journal of interventional cardiology.

GENDER DISPARITIES WITH RESPECT TO CORRELATES FOR CLINICAL ADVERSE OUTCOMES AFTER CONTEMPORARY PCI IN PATIENTS WITH ACS

I. Barbash, D. Dvir, A. Pichard, 2013 .

The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome.

W. Weintraub, A. Pichard, L. Satler, 2018, Cardiovascular revascularization medicine : including molecular interventions.

Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.

I. Barbash, D. Dvir, A. Pichard, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary intervention.

I. Barbash, A. Pichard, L. Satler, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity.

R. Torguson, P. Gurbel, R. Waksman, 2015, The American journal of cardiology.

Use of emergency medical services expedites in-hospital care processes in patients presenting with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock.

A. Pichard, L. Satler, R. Torguson, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Intracoronary radiation therapy using a novel beta emitter for in-stent restenosis Tungsten WRIST.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.

G. Lemesle, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

The impact of diabetes mellitus on outcome of patients undergoing transcatheter aortic valve replacement

I. Barbash, A. Pichard, L. Satler, 2015 .

Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes in diabetic versus nondiabetic patients who present with acute myocardial infarction and are treated with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients.

H. Suryapranata, D. Kandzari, M. de Boer, 2014, Atherosclerosis.

The predictive value of computed tomography calcium scores: a comparison with quantitative volumetric intravascular ultrasound.

N. Weissman, G. Mintz, K. Kent, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Cardiovascular risk among ultra-endurance runners.

M. Hoffman, R. Torguson, U. Khan, 2021, The Journal of sports medicine and physical fitness.

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Should Non-ST-Elevation Myocardial Infarction be Treated like ST-Elevation Myocardial Infarction With Shorter Door-to-Balloon Time?

W. Weintraub, R. Torguson, R. Waksman, 2019, The American journal of cardiology.

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type.

A. Pichard, L. Satler, A. Steinvil, 2016, The American journal of cardiology.

Prognosis of asymptomatic coronary artery disease after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, American Journal of Cardiology.

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction.

K. Kent, A. Pichard, L. Satler, 2012, The American journal of cardiology.

Qualitative comparison of coronary angiograms between 4 french catheters with an Advanced Cardiovascular Injection System and 6 french catheters with manual injection

A. Pichard, L. Satler, R. Torguson, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention.

R. Torguson, H. Garcia-Garcia, R. Waksman, 2019, The American journal of cardiology.

Comparison of the Efficacy and Safety of Orbital and Rotational Atherectomy in Calcified Narrowings in Patients Who Underwent Percutaneous Coronary Intervention.

A. Pichard, L. Satler, A. Steinvil, 2018, The American journal of cardiology.

Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromes.

K. Kent, A. Pichard, L. Satler, 2010, Journal of interventional cardiology.

The clinical significance of hematocrit values before and after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation.

I. Barbash, K. Kent, A. Pichard, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation

K. Kent, A. Pichard, L. Satler, 2010, Circulation.

Utility of radiologic review for noncardiac findings on multislice computed tomography in patients with severe aortic stenosis evaluated for transcatheter aortic valve implantation.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Use of IIb/IIIa inhibitors in patients with in‐stent restenosis treated with intracoronary γ‐radiation: Integrilin WRIST

K. Kent, A. Pichard, L. Satler, 2004, Catheterization and cardiovascular interventions.

One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery.

Brian C. Case, G. Mintz, L. Satler, 2021, The American journal of cardiology.

Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2012, Journal of interventional cardiology.

Aortic valve ChromaFlo®: a feasibility study of aortic regurgitation and effective annular aortic area assessment in a porcine model.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Impact of two formulas to calculate percentage diameter stenosis of coronary lesions: from stenosis models (phantom lesion model) to actual clinical lesions

R. Torguson, H. Garcia-Garcia, R. Waksman, 2019, The International Journal of Cardiovascular Imaging.

Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.

K. Kent, A. Pichard, L. Satler, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention.

R. Torguson, R. Waksman, M. Gaglia, 2011, Journal of interventional cardiology.

Switching patients from clopidogrel to prasugrel in acute coronary syndrome: impact of the clopidogrel loading dose on platelet reactivity.

R. Torguson, R. Waksman, T. Lhermusier, 2014, Journal of interventional cardiology.

Racial disparity with on-treatment platelet reactivity in patients undergoing percutaneous coronary intervention.

I. Barbash, A. Pichard, L. Satler, 2013, American heart journal.

Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2013, The American journal of cardiology.

Relation of body mass index to on-treatment (clopidogrel + aspirin) platelet reactivity.

K. Kent, A. Pichard, L. Satler, 2011, The American journal of cardiology.

Response to Letters Regarding Article, “Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?”

G. Lemesle, K. Kent, A. Pichard, 2011 .

A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.

R. Torguson, R. Waksman, M. Lipinski, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.

A. Pichard, L. Satler, S. Collins, 2010, Journal of interventional cardiology.

Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Outcomes in patients with intra-aortic balloon pump who met the same inclusion criteria in the PROTECT II (a prospective feasibility trial investigating the use of the impella recover LP 2.5 system in patients undergoing high risk percutaneous coronary intervention) Study

G. Lemesle, K. Kent, A. Pichard, 2009 .

Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non-roller-type cardiopulmonary bypass blood pump devices.

R. Torguson, R. Waksman, S. Minha, 2013, American heart journal.

Safety and efficacy of prasugrel use in patients undergoing percutaneous coronary intervention and anticoagulated with bivalirudin.

K. Kent, A. Pichard, L. Satler, 2013, American Journal of Cardiology.

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?

G. Lemesle, K. Kent, A. Pichard, 2010, Cardiovascular revascularization medicine : including molecular interventions.

Procedural Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention During Normal Work Hours versus Non-Work Hours.

Brian C. Case, W. Weintraub, L. Satler, 2020, The American journal of cardiology.

CORONARY ARTERY DISEASE Original Studies Outcomes of Concomitant Percutaneous Coronary Intervention and Balloon Aortic Valvuloplasty

A. Pichard, L. Satler, R. Torguson, 2013 .

Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients.

K. Kent, A. Pichard, L. Satler, 2010, JACC. Cardiovascular interventions.

COMPLICATIONS AND OUTCOMES OF BALLOON AORTIC VALVULOPLASTY IN HIGH-RISK OR INOPERABLE PATIENTS

K. Kent, A. Pichard, L. Satler, 2010 .

Clinical Frailty as an Outcome Predictor After Transcatheter Aortic Valve Implantation.

L. Satler, A. Steinvil, R. Torguson, 2018, The American journal of cardiology.

Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stent.

D. Dvir, R. Torguson, R. Waksman, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary intervention after acute myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2006, Cardiovascular revascularization medicine : including molecular interventions.

Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy who present with an acute coronary syndrome and undergo percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2011, American Journal of Cardiology.

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, American heart journal.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, American Journal of Cardiology.

Outcome of Left-Sided Cardiac Remodeling in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation.

A. Pichard, L. Satler, F. Asch, 2015, The American journal of cardiology.

Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

A. Pichard, L. Satler, R. Torguson, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation.

I. Barbash, D. Dvir, A. Pichard, 2012, The American journal of cardiology.

Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Impact of left ventricular outflow tract calcification on outcomes following transcatheter aortic valve replacement.

Brian C. Case, L. Satler, R. Torguson, 2021, Cardiovascular revascularization medicine : including molecular interventions.

The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement.

A. Pichard, L. Satler, R. Torguson, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.

I. Barbash, A. Pichard, L. Satler, 2014, American Journal of Cardiology.

The AngelMed Guardian system: Is there a role for implantable devices for early detection of coronary artery occlusion?

A. Steinvil, R. Torguson, R. Waksman, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Accuracy of predicted orthogonal projection angles for valve deployment during transcatheter aortic valve replacement.

L. Satler, A. Steinvil, R. Torguson, 2018, Journal of cardiovascular computed tomography.

The influence of lipid-containing plaque composition assessed by near-infrared spectroscopy on coronary lesion remodelling.

A. Pichard, L. Satler, R. Torguson, 2016, European heart journal cardiovascular Imaging.

Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement.

I. Barbash, A. Pichard, L. Satler, 2015, The American journal of cardiology.

Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement

I. Barbash, D. Dvir, A. Pichard, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of closure strategies after balloon aortic valvuloplasty: Suture mediated versus collagen based versus manual

A. Pichard, L. Satler, R. Torguson, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients.

M. Buchbinder, T. Bilfinger, L. Satler, 2020, JACC. Cardiovascular interventions.

Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis.

H. Garcia-Garcia, A. Pichard, L. Satler, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.

A. Pichard, L. Satler, A. Steinvil, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Abstract 4542: Does Proton Pump Inhibitor Use Following Percutaneous Coronary Intervention With Drug-eluting Stents Impact Clinical Outcome?

K. Kent, A. Pichard, L. Satler, 2009 .

Overview of the 2013 Food and Drug Administration Circulatory System Devices Panel Meeting on the MitraClip Delivery System

R. Torguson, R. Waksman, S. Minha, 2013, Circulation.

Association between bleeding severity and long-term mortality in patients experiencing vascular complications after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2012, The American journal of cardiology.

Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).

G. Mintz, R. Torguson, H. Garcia-Garcia, 2021, International journal of cardiology.

FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study.

R. Torguson, R. Waksman, S. Marso, 2013, Journal of the American College of Cardiology.

Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safety

M. Mack, E. Tuzcu, L. Svensson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Reasons for Screen Failure for Transcatheter Mitral Valve Repair and Replacement.

Brian C. Case, L. Satler, R. Torguson, 2021, The American journal of cardiology.

MitraClip 30-day readmissions and impact of early discharge: An analysis from the nationwide readmissions database 2016.

Brian C. Case, L. Satler, R. Torguson, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Inappropriate use of risk score models for operative mortality in nonsurgical treatments

R. Torguson, W. Suddath, Petros G. Okubagzi, 2012 .

Insurance Type Inﬂuences the Use of Drug-Eluting Stents

A. Pichard, L. Satler, S. Collins, 2022 .

Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor.

L. Wallentin, A. Steinvil, R. Torguson, 2017, The American journal of cardiology.

Clinical predictors for failure of percutaneous coronary intervention in ST-elevation myocardial infarction.

I. Barbash, A. Pichard, L. Satler, 2012, Journal of interventional cardiology.

Impact of smoking on acute phase outcomes of myocardial infarction

K. Kent, A. Pichard, L. Satler, 2011, Coronary Artery Disease.

Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?

A. Pichard, L. Satler, R. Torguson, 2014, American heart journal.

The IMPact on Revascularization Outcomes of intraVascular ultrasound-guided treatment of complex lesions and Economic impact (IMPROVE) trial: Study design and rationale.

Binita Shah, C. Di Mario, W. Weintraub, 2020, American heart journal.

Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial.

M. Buchbinder, T. Bilfinger, L. Satler, 2019, American heart journal.

Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era

L. Satler, R. Torguson, R. Waksman, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Techniques to Optimize the Use of Optical Coherence Tomography: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.

H. Garcia-Garcia, R. Torguson, R. Waksman, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Prosthetic valve endocarditis after transcatheter aortic valve replacement in low‐risk patients

Brian C. Case, L. Satler, F. Asch, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study.

R. Torguson, R. Waksman, P. Corso, 2017, American heart journal.

Contemporary transcatheter aortic valve replacement with third‐generation balloon‐expandable versus self‐expanding devices

A. Pichard, L. Satler, A. Steinvil, 2017, Journal of interventional cardiology.

Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis.

A. Pichard, L. Satler, R. Torguson, 2016, The American journal of cardiology.

Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System.

A. Steinvil, R. Torguson, R. Waksman, 2016, JACC. Cardiovascular interventions.

Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.

I. Barbash, D. Dvir, A. Pichard, 2013, American Journal of Cardiology.

Comparison of stent axial integrity in first- versus second-generation drug-eluting stents: insights from intravascular ultrasound analysis

D. Dvir, A. Pichard, L. Satler, 2013 .

Impact of Baseline Left Ventricular Diastolic Dysfunction in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.

A. Pichard, L. Satler, F. Asch, 2019, The American journal of cardiology.

Association of Right Ventricular Longitudinal Strain with Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.

L. Satler, F. Asch, R. Torguson, 2020, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Usefulness of Longitudinal Strain to Assess Remodeling of Right and Left Cardiac Chambers Following Transcatheter Aortic Valve Implantation.

L. Satler, F. Asch, S. Goldstein, 2019, The American journal of cardiology.

Impact of previous coronary artery bypass grafting on patients undergoing transcatheter aortic valve implantation for aortic stenosis.

I. Barbash, D. Dvir, K. Kent, 2014, The American journal of cardiology.

Prevalence and effect of myocardial injury after transcatheter aortic valve replacement.

I. Barbash, D. Dvir, A. Pichard, 2013, The American journal of cardiology.

Characteristics and Outcomes of Patients with Inflammatory Cardiomyopathies Receiving Mechanical Circulatory Support: An STS-Intermacs Registry Analysis.

S. Najjar, W. Weintraub, R. Torguson, 2021, Journal of cardiac failure.

Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review.

Brian C. Case, W. Weintraub, R. Torguson, 2020, Journal of the American College of Cardiology.

Risk of mortality with paclitaxel drug-coated balloon in de novo coronary artery disease.

Brian C. Case, W. Weintraub, R. Torguson, 2020, Cardiovascular revascularization medicine : including molecular interventions.

A patient-level, pooled analysis of mortality rates with the Passeo-18 Lux paclitaxel drug-coated balloon in peripheral arterial disease.

Brian C. Case, R. Torguson, Charan T. Yerasi, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Additive effect of multiple high-risk coronary artery segments on patient outcomes: LRP Study sub-analysis.

Brian C. Case, C. Di Mario, G. Mintz, 2022, Cardiovascular revascularization medicine : including molecular interventions.

Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement

A. Pichard, L. Satler, A. Steinvil, 2018, American heart journal.

Society of Thoracic Surgeons Score Variance Results in Risk Reclassification of Patients Undergoing Transcatheter Aortic Valve Replacement

R. Torguson, R. Waksman, Jiaxiang Gai, 2017, JAMA cardiology.

Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement.

A. Pichard, L. Satler, R. Torguson, 2016, American heart journal.

Comparison of Propensity Score-Matched Analysis of Acute Kidney Injury After Percutaneous Coronary Intervention With Transradial Versus Transfemoral Approaches.

A. Pichard, L. Satler, A. Steinvil, 2017, The American journal of cardiology.

Definitions of periprocedural myocardial infarction as surrogates for catheterization laboratory quality or clinical trial end points.

R. Torguson, R. Waksman, M. Lipinski, 2014, The American journal of cardiology.

Impact of blood transfusions on short- and long-term mortality in patients who underwent transcatheter aortic valve implantation.

A. Pichard, L. Satler, R. Torguson, 2015, The American journal of cardiology.

Intraprocedural invasive hemodynamic parameters as predictors of short- and long-term outcomes in patients undergoing transcatheter aortic valve replacement.

A. Pichard, L. Satler, A. Steinvil, 2017, Cardiovascular revascularization medicine : including molecular interventions.

The story is not yet "COMPLETE".

R. Torguson, Brian J. Forrestal, R. Waksman, 2020, Cardiovascular revascularization medicine : including molecular interventions.

CORONARY ARTERY DISEASE Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

G. Lemesle, K. Kent, A. Pichard, 2009 .

Meta-Analysis of the Impact of Strut Thickness on Outcomes in Patients With Drug-Eluting Stents in a Coronary Artery.

W. Weintraub, R. Torguson, Brian J. Forrestal, 2018, The American journal of cardiology.

Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Combined Vascular Brachytherapy and Stenting for the Treatment of In-Stent Restenosis.

L. Satler, R. Torguson, R. Waksman, 2019, The American journal of cardiology.

Treatment of Patients with Recurrent Coronary In-Stent Restenosis with Failed Intravascular Brachytherapy.

Brian C. Case, L. Satler, R. Torguson, 2020, The American journal of cardiology.

Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?

K. Kent, A. Pichard, L. Satler, 2010, American heart journal.

Correlates and Significance of Elevation of Cardiac Biomarkers Elevation Following Transcatheter Aortic Valve Implantation.

A. Pichard, L. Satler, A. Steinvil, 2017, The American journal of cardiology.

Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry).

I. Barbash, D. Dvir, A. Pichard, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study.

J. Wykrzykowska, Z. Ali, C. Di Mario, 2021, European heart journal. Cardiovascular Imaging.

Impact of triggering event in outcomes of stress-induced (Takotsubo) cardiomyopathy

A. Pichard, L. Satler, R. Torguson, 2017, European heart journal. Acute cardiovascular care.

Outcomes of patients with acute myocardial infarction rom a saphenous vein graft culprit undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2011, Catheterization and cardiovascular interventions.

Safety and long‐term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus

A. Pichard, L. Satler, R. Torguson, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2011, Journal of interventional cardiology.

Patient characteristics in variable left ventricular recovery from Takotsubo syndrome.

A. Pichard, L. Satler, R. Torguson, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support

Brian C. Case, L. Satler, R. Torguson, 2021, Circulation. Cardiovascular interventions.

Impact of cangrelor on coronary thrombus: Optical coherence tomography assessment.

A. Jeremias, H. Garcia-Garcia, R. Torguson, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Balloon-expandable valve geometry after transcatheter aortic valve replacement in low-risk patients with bicuspid versus tricuspid aortic stenosis.

Brian C. Case, M. Buchbinder, H. Garcia-Garcia, 2021, Cardiovascular revascularization medicine : including molecular interventions.

National trends and 30-day readmission rates for next-day-discharge TAVR: An analysis from the Nationwide readmissions database, 2012-2016.

Brian C. Case, W. Weintraub, L. Satler, 2020, American heart journal.

Impact of in-stent restenosis on death and myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Impact of baseline imaging of non-culprit coronary lesions and adverse events: Insight from LRP study.

Brian C. Case, G. Mintz, R. Torguson, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Comparison between sirolimus‐ and paclitaxel‐eluting stents in complex patient and lesions subsets

K. Kent, A. Pichard, R. Torguson, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Choice of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Impacts Hemodynamics Differently According to Aortic Annular Size.

A. Pichard, L. Satler, A. Steinvil, 2017, The American journal of cardiology.

Utility of Invasive Electrophysiology Studies in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.

A. Pichard, L. Satler, A. Steinvil, 2018, The American journal of cardiology.

Role of contractile reserve as a predictor of mortality in low‐flow, low‐gradient severe aortic stenosis following transcatheter aortic valve replacement

A. Pichard, L. Satler, F. Asch, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2008, American Journal of Cardiology.

The influence of advancing age on implantation of drug‐eluting stents

A. Pichard, L. Satler, R. Torguson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial.

K. Kent, L. Satler, R. Wolfram, 2006, The Journal of invasive cardiology.

Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis.

R. Torguson, R. Waksman, M. Lipinski, 2016, Journal of interventional cardiology.

Incidence and correlates in the development of iatrogenic femoral pseudoaneurysm after percutaneous coronary interventions.

A. Pichard, L. Satler, R. Torguson, 2014, Journal of interventional cardiology.

A novel, minimally invasive access technique versus standard 18‐gauge needle set for femoral access

A. Pichard, L. Satler, R. Torguson, 2012 .

Noninferiority Margins in Clinical Trials-A Moving Target?

A. Farb, Lina Wang, R. Torguson, 2022, JAMA cardiology.

Safety of eptifibatide when added to bivalirudin during ST-segment elevation myocardial infarction.

R. Torguson, R. Waksman, M. Lipinski, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System.

R. Torguson, R. Waksman, Toby Rogers, 2017, American heart journal.

The impact of live case transmission on patient outcomes during transcatheter aortic valve replacement: results from the VERITAS study.

J. Webb, A. Colombo, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

The impact of diabetes mellitus on long-term clinical outcomes after percutaneous coronary saphenous vein graft interventions in the drug-eluting stent era.

A. Pichard, L. Satler, R. Torguson, 2014, Journal of interventional cardiology.

Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Aortic Valve Disease and TreatmentTCT-747 Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

M. Mack, E. Tuzcu, L. Svensson, 2013 .

Contemporary Use of Veno-Arterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Acute Coronary Syndrome.

A. Pichard, L. Satler, R. Torguson, 2016, The Journal of invasive cardiology.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of overlapping drug‐eluting stents in patients undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of everolimus-eluting stents compared with first-generation drug-eluting stents in patients undergoing primary percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular Revascularization Medicine.

Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial).

T. Ryan, R. Torguson, R. Waksman, 2012, The American journal of cardiology.

Real-time, two-way interaction during ST-segment elevation myocardial infarction management improves door-to-balloon times.

L. Satler, R. Torguson, R. Waksman, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Cardiovascular Phenotyping in Breast Cancer Patients Treated With Her2 Targeted Therapies Using Informatics Approaches

F. Asch, S. Boca, P. Pohlmann, 2020 .

Adverse Events Related to Orbital Atherectomy: Lessons Learned from an Analytic Review of the MAUDE Database.

R. Torguson, R. Waksman, Toby Rogers, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve

Brian C. Case, C. Zhang, L. Satler, 2020, Circulation. Cardiovascular interventions.

Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study.

Brian C. Case, M. Buchbinder, L. Satler, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel meeting on the INCRAFT AAA Stent Graft System.

R. Torguson, R. Waksman, N. Bernardo, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Mortality in patients requiring pacemaker implantation following transcatheter aortic valve replacement: insights from a systematic review and meta-analysis.

R. Torguson, R. Waksman, M. Lipinski, 2014, International journal of cardiology.

A single center experience of Zilver PTX for femoro-popliteal lesions.

R. Torguson, R. Waksman, M. Lipinski, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Operator learning curve for transradial percutaneous coronary interventions: implications for the initiation of a transradial access program in contemporary US practice.

I. Barbash, A. Pichard, L. Satler, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Prognostic implications of percutaneous coronary interventions performed according to the appropriate use criteria for coronary revascularization.

I. Barbash, D. Dvir, A. Pichard, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Safety and efficacy of everolimus‐eluting stents versus paclitaxel‐eluting stents in a diabetic population

I. Barbash, A. Pichard, L. Satler, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Anatomical characteristics associated with hypoattenuated leaflet thickening in low-risk patients undergoing transcatheter aortic valve replacement.

M. Buchbinder, H. Garcia-Garcia, T. Bilfinger, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Coronary Artery Disease Assessed by Computed Tomography-Based Leaman Score in Patients With Low-Risk Transcatheter Aortic Valve Implantation.

M. Buchbinder, H. Garcia-Garcia, T. Bilfinger, 2020, The American journal of cardiology.

Comparison of intracoronary gamma radiation for in-stent restenosis in saphenous vein grafts versus native coronary arteries.

K. Kent, A. Pichard, L. Satler, 2003, The American journal of cardiology.

Comparison of outcome of higher versus lower transvalvular gradients in patients with severe aortic stenosis and low (<40%) left ventricular ejection fraction.

A. Pichard, L. Satler, S. Goldstein, 2012, The American journal of cardiology.

Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high‐volume Center in the United States

A. Pichard, L. Satler, A. Steinvil, 2018, American heart journal.

In-Stent Restenosis of Drug-Eluting Stents Compared With a Matched Group of Patients With De Novo Coronary Artery Stenosis.

L. Satler, R. Torguson, R. Waksman, 2018, The American journal of cardiology.

Reply: To PMID 23352786.

R. Torguson, R. Waksman, J. Legutko, 2013, Journal of the American College of Cardiology.

Impact of close surveillance on dual-antiplatelet therapy compliance in myocardial infarction patients post-percutaneous coronary intervention.

Brian C. Case, L. Satler, R. Torguson, 2022, Cardiovascular revascularization medicine : including molecular interventions.

MynxGrip® vascular closure device versus manual compression for hemostasis of percutaneous transfemoral venous access closure: Results from a prospective multicenter randomized study.

A. Pichard, L. Satler, R. Torguson, 2018, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of coronary revascularization appropriateness for non‐acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria

Brian C. Case, A. Pichard, L. Satler, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three‐year follow‐up after intravascular γ‐radiation for in‐stent restenosis in saphenous vein grafts

P. Teirstein, K. Kent, A. Pichard, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the AngelMed Guardian System.

A. Steinvil, R. Torguson, R. Waksman, 2016, Circulation.

How should we manage thrombosis of Viabahn stent-graft? A case report focused on catheter-directed thrombolysis.

R. Torguson, R. Waksman, M. Lipinski, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2006, Circulation.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Impact of Intravascular Ultrasound on Outcomes Following PErcutaneous Coronary InterventioN in Complex Lesions (iOPEN Complex).

G. Mintz, L. Satler, R. Torguson, 2019, American heart journal.

Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions.

K. Kent, A. Pichard, L. Satler, 2012, Journal of interventional cardiology.

Comparison of Bleeding Outcomes After Percutaneous Coronary Intervention in Patients With Versus Without Aortic Stenosis.

A. Pichard, L. Satler, R. Torguson, 2015, American Journal of Cardiology.

Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.

K. Kent, A. Pichard, L. Satler, 2005, The Journal of invasive cardiology.

Overview of the virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for below-the-knee lesions in critical limb ischemia.

Brian C. Case, R. Torguson, R. Waksman, 2021, Cardiovascular revascularization medicine : including molecular interventions.

R. Torguson, H. Garcia-Garcia, R. Waksman, 2019, American heart journal.

Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall.

R. Torguson, H. Garcia-Garcia, R. Waksman, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Retroperitoneal hemorrhage after percutaneous coronary intervention in the current practice era: Clinical outcomes and prognostic value of abdominal/pelvic computed tomography

A. Pichard, R. Torguson, R. Waksman, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease

K. Kent, A. Pichard, L. Satler, 2007, Circulation.

Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients.

T. L. Pinto, K. Kent, A. Pichard, 2006, The American journal of cardiology.

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.

Michael J Lipinski, Ron Waksman, R. Torguson, 2016, JACC. Cardiovascular interventions.

Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes.

A. Kirtane, M. Leon, I. Barbash, 2014, European heart journal.

Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).

T. Ryan, L. Räber, A. Kirtane, 2014, JACC. Cardiovascular interventions.

Prevalence and predictors of left atrial thrombus in patients with atrial fibrillation: is transesophageal echocardiography necessary before cardioversion?

S. Goldstein, R. Torguson, R. Waksman, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Body mass index association with survival in severe aortic stenosis patients undergoing transcatheter aortic valve replacement

A. Pichard, L. Satler, R. Torguson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Current application and bioavailability of drug-eluting stents

R. Torguson, R. Waksman, M. Lipinski, 2014, Expert opinion on drug delivery.

A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome.

P. Fitzgerald, N. Weissman, H. Brewer, 2010, Journal of the American College of Cardiology.

Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2013, Catheterization and cardiovascular interventions.

Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents.

G. Lemesle, A. Pichard, L. Satler, 2009, Journal of interventional cardiology.

Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials.

A. Pichard, L. Satler, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Brachytherapy and bivalirudin evaluation study.

K. Kent, A. Pichard, L. Satler, 2005, American heart journal.

A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease!

K. Kent, A. Pichard, L. Satler, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade.

K. Kent, A. Pichard, L. Satler, 2012, Cardiovascular revascularization medicine : including molecular interventions.

Sirolimus‐eluting stents and calcified coronary lesions: Clinical outcomes of patients treated with and without rotational atherectomy

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of everolimus-eluting stents for bare-metal in-stent restenosis.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

A novel percutaneous coronary intervention risk score to predict one-year mortality.

A. Pichard, L. Satler, S. Collins, 2010, The American journal of cardiology.

Impact of three or more sirolimus‐eluting stents versus paclitaxel‐eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device?

K. Kent, A. Pichard, L. Satler, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: results from the ClearWay™ Multicenter Registry.

R. Torguson, R. Waksman, G. Revtyak, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Intravascular ultrasound analysis to determine the relationship between high-density lipoprotein cholesterol and lesion characteristics in patients with coronary artery disease.

H. Brewer, A. Pichard, R. Torguson, 2014, Journal of interventional cardiology.

Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study

Habib Samady, Francesco Prati, Eric Powers, 2019, The Lancet.

Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure.

Pamela Randolph, Ron Waksman, A. Pichard, 2016, JACC. Cardiovascular interventions.

Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.

Joseph Lindsay, Kohei Wakabayashi, Ron Waksman, 2010, The American journal of cardiology.

Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).

A. Pichard, L. Satler, R. Torguson, 2014, The American journal of cardiology.

Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, Journal of interventional cardiology.

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

G. Lemesle, K. Kent, A. Pichard, 2010, Circulation.

Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis

K. Kent, A. Pichard, L. Satler, 2004, Circulation.

Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, Cardiovascular revascularization medicine : including molecular interventions.

Outcome comparison of African‐American and caucasian patients with severe aortic stenosis subjected to transcatheter aortic valve replacement: A single‐center experience

I. Barbash, A. Pichard, L. Satler, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Cellular video-phone assisted transmission and interpretation of prehospital 12-lead electrocardiogram in acute st-segment elevation myocardial infarction.

A. Pichard, L. Satler, R. Torguson, 2011, Journal of interventional cardiology.

Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.

A. Pichard, L. Satler, R. Torguson, 2014, The American journal of cardiology.

A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction.

M. Sebbane, Ò. Miró, S. Epstein, 2014, The American journal of cardiology.

Relation of Sex and Race to Outcomes in Patients Undergoing Percutaneous Intervention With Drug-Eluting Stents.

W. Weintraub, L. Satler, R. Torguson, 2019, The American journal of cardiology.

Association of Statins With Nonculprit Coronary Lesions and Adverse Events (from the LRP Study).

Brian C. Case, C. Di Mario, G. Mintz, 2022, The American journal of cardiology.

Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.

Z. Ali, C. Di Mario, G. Mintz, 2021, Atherosclerosis.

Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduits.

I. Barbash, D. Dvir, K. Kent, 2013, The American journal of cardiology.

Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment.

N. Weissman, G. Mintz, K. Kent, 2007, The American journal of cardiology.

In vivo evaluation of axial integrity of coronary stents using intravascular ultrasound: Insights on longitudinal stent deformation

I. Barbash, D. Dvir, R. Torguson, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Relation of drug-eluting stent strut distribution to stent thrombosis in coronary arteries.

N. Weissman, G. Mintz, K. Kent, 2009, The American journal of cardiology.

PROGNOSTIC SIGNIFICANCE OF AN ELEVATED CONVENTIONAL OR HIGH-SENSITIVITY CARDIAC TROPONIN IN PATIENTS WITH CHEST PAIN WITH AND WITHOUT A DIAGNOSIS OF MYOCARDIAL INFARCTION

A. Jaffe, P. Collinson, B. Lindahl, 2015 .

Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention with Drug Eluting Stents.

Samin K. Sharma, G. Dangas, R. Mehran, 2020, The American journal of cardiology.

Effect of marital status on the outcome of patients undergoing elective or urgent coronary revascularization.

I. Barbash, A. Pichard, L. Satler, 2013, American heart journal.

Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis.

R. Torguson, R. Waksman, M. Lipinski, 2016, International journal of cardiology.

TCT-759 Comparison Of Watchman Device With New Oral Anti-Coagulants In Patients With Atrial Fibrillation: A Network Meta-Analysis

R. Torguson, R. Waksman, M. Lipinski, 2015 .

AORTIC VALVE CALCIUM SCORE BY COMPUTED TOMOGRAPHY IN PREDICTING PERIVALVULAR AORTIC INSUFFICIENCY POST TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)

Allen J. Taylor, A. Pichard, L. Satler, 2012 .

Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement.

A. Pichard, L. Satler, R. Torguson, 2015, The American journal of cardiology.

Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.

A. Pichard, L. Satler, F. Asch, 2016, The American journal of cardiology.

Impact of transcatheter aortic valve replacement on risk profiles of surgical aortic valve replacement patients.

T. Bilfinger, V. Thourani, R. Torguson, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings.

N. Weissman, G. Mintz, K. Kent, 2008, The American journal of cardiology.

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.

N. Weissman, K. Kent, A. Pichard, 2004, Journal of the American College of Cardiology.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Coronary perfusion pressure and left ventricular hemodynamics as predictors of cardiovascular collapse following percutaneous coronary intervention.

L. Satler, R. Torguson, R. Waksman, 2019, Cardiovascular Revascularization Medicine.

Second-generation everolimus-eluting stents compared to first-generation drug-eluting stents in patients treated for multivessel disease.

I. Barbash, D. Dvir, A. Pichard, 2013, Journal of interventional cardiology.

Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions.

A. Pichard, L. Satler, R. Torguson, 2012, Journal of interventional cardiology.

Patients With Severe Asymptomatic Carotid Artery Stenosis Do Not Have a Higher Risk of Stroke and Mortality After Coronary Artery Bypass Surgery

R. Torguson, R. Waksman, P. Corso, 2011, Stroke.

Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

A. Pichard, L. Satler, F. Asch, 2017, American heart journal.

Trends in Death Rate 2009 to 2018 Following Percutaneous Coronary Intervention Stratified by Acuteness of Presentation.

W. Weintraub, L. Satler, R. Torguson, 2019, The American journal of cardiology.

Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.

A. Pichard, L. Satler, F. Asch, 2016, American Heart Journal.

The Lipid-Rich Plaque Study of vulnerable plaques and vulnerable patients: Study design and rationale.

J. Ware, R. Torguson, R. Waksman, 2017, American heart journal.

Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis.

M. Sebbane, A. Jaffe, P. Collinson, 2015, American heart journal.

Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement With the Self-Expanding CoreValve Versus the Balloon-Expandable SAPIEN XT Valve.

A. Pichard, L. Satler, F. Asch, 2016, The American journal of cardiology.

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.

T. L. Pinto, K. Kent, A. Pichard, 2006, Cardiovascular revascularization medicine : including molecular interventions.

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.

S. Silber, P. Stella, G. Sangiorgi, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Non-culprit MACE-rate in LRP: The influence of optimal medical therapy using DAPT and statins.

R. D. de Winter, J. Wykrzykowska, Z. Ali, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.

N. Weissman, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

A comparison of the ultrathin Orsiro Hybrid sirolimus-eluting stent with contemporary drug-eluting stents: A meta-analysis of randomized controlled trials.

R. Torguson, Brian J. Forrestal, R. Waksman, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction Model.

R. Lederman, P. Codner, R. Torguson, 2023, JACC. Cardiovascular interventions.

Platelet reactivity in diabetic patients subjected to acute exercise stress test.

G. Lemesle, A. Pichard, M. Scheinowitz, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Near-infrared spectroscopy predicts events in men and women: Results from the Lipid Rich Plaque study

Z. Ali, C. Di Mario, R. Geuns, 2022, International journal of cardiology. Heart & vasculature.

Role of near-infrared spectroscopy in intravascular coronary imaging.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular Revascularization Medicine.

Does direct stenting with drug‐eluting stents improve outcome? A meta‐analysis of 10,900 patients

A. Pichard, L. Satler, R. Torguson, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial.

R. Torguson, R. Waksman, F. Malik, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.

D. Kereiakes, R. Torguson, R. Waksman, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Clinical Outcomes and Treatment After Drug-Eluting Stent Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis

K. Kent, A. Pichard, L. Satler, 2012, Circulation. Cardiovascular interventions.

Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Synergistic increase risk of death and myocardial infarction at one year in patients with concomitant diabetes mellitus and renal failure

A. Pichard, L. Satler, S. Collins, 2010 .

Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.

I. Barbash, A. Pichard, L. Satler, 2014, The Journal of invasive cardiology.

Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, International journal of cardiology.

Procedural results and outcomes after extensive stent coverage with drug-eluting stent implantation in single coronary lesions.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Comparison of long-term outcomes between everolimus-eluting and sirolimus-eluting stents in small vessels.

I. Barbash, D. Dvir, K. Kent, 2013, The American journal of cardiology.

Selective versus exclusive use of sirolimus‐eluting stent implantation in multivessel coronary artery disease

K. Kent, A. Pichard, L. Satler, 2005, Catheterization and cardiovascular interventions.

Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry).

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Comparison of frequency and severity of longitudinal stent deformation among various drug-eluting stents: an intravascular ultrasound study.

A. Pichard, L. Satler, R. Torguson, 2014, International journal of cardiology.

Promus Premier versus Xience V and Taxus Liberte in contemporary United States practice (REWARDS premier registry).

Thomas D. Scott, T. Nazif, R. Torguson, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents.

I. Barbash, D. Dvir, K. Kent, 2013, The American journal of cardiology.

Long‐term safety and efficacy of second‐generation everolimus‐eluting stents compared to other limus‐eluting stents and bare metal stents in patients with acute coronary syndrome

A. Pichard, L. Satler, R. Torguson, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel.

Raghava R. Gollapudi, C. Grines, S. Ellis, 2017, JACC. Cardiovascular interventions.

Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.

K. Kent, A. Pichard, L. Satler, 2011, The American journal of cardiology.

Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus.

S. Saito, S. Windecker, D. Kandzari, 2019, The American journal of cardiology.

Procedural Outcomes of Patients Undergoing Percutaneous Coronary Intervention for De Novo Lesions in the Ostial and Proximal Left Circumflex Coronary Artery.

Brian C. Case, G. Mintz, L. Satler, 2020, The American journal of cardiology.

Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model

R. Virmani, F. Kolodgie, M. Joner, 2017, Circulation. Cardiovascular interventions.

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents.

A. Pichard, L. Satler, R. Torguson, 2007, Journal of interventional cardiology.

Vascular brachytherapy for patients with drug-eluting stent restenosis.

G. Lemesle, A. Pichard, L. Satler, 2008, Journal of interventional cardiology.

Impact of sirolimus‐eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty

K. Kent, A. Pichard, L. Satler, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of Rotational Atherectomy, Plain Old Balloon Angioplasty, and Cutting-Balloon Angioplasty Prior to Drug-Eluting Stent Implantation for the Treatment of Heavily Calcified Coronary Lesions.

A. Pichard, L. Satler, R. Torguson, 2015, The Journal of invasive cardiology.

Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis and Prior External Chest Radiation.

S. Attaran, W. Weintraub, L. Satler, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?" (Cardiovasc Revasc Med 2010;11(2):91–7)

G. Lemesle, K. Kent, A. Pichard, 2011 .

Does on‐ versus off‐hours presentation impact in‐hospital outcomes of ST‐segment elevation myocardial infarction patients transferred to a tertiary care center?

A. Pichard, L. Satler, S. Collins, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Technical performance

John Ehrlinger, Jeevanantham Rajeswaran, Eugene H Blackstone, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Adverse Events and Modes of Failure Related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.

R. Torguson, R. Waksman, D. Gajanana, 2019, Cardiovascular revascularization medicine : including molecular interventions.

ral Rapamycin to Inhibit Restenosis fter Stenting of De Novo Coronary Lesions he Oral Rapamune to Inhibit Restenosis ( ORBIT ) Study on Waksman , MD , *

N. Weissman, K. Kent, A. Pichard, 2016 .

Disparities among black and white patients in plaque burden and composition and long-term impact

Z. Ali, C. Di Mario, G. Mintz, 2023, Cardiovascular Revascularization Medicine.

CLINICAL OUTCOMES FOLLOWING UNRESTRICTED USE OF THE EVEROLIMUS-ELUTING STENT AS COMPARED WITH PACLITAXEL- AND SIROLIMUS-ELUTING STENTS

K. Kent, A. Pichard, L. Satler, 2011 .

Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the Xience V Everolimus-Eluting Coronary Stent.

R. Torguson, R. Waksman, R. Waksman, 2008, The American journal of cardiology.

Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Changes in mitral regurgitation after balloon aortic valvuloplasty.

I. Barbash, K. Kent, A. Pichard, 2011, The American journal of cardiology.

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis.

A. Pichard, L. Satler, R. Torguson, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abstract 13675: The Impact of Major Vascular Complications on the Long-Term Outcome for Patient Undergoing Trans-Catheter Aortic Valve Replacement

I. Barbash, L. Satler, R. Torguson, 2014 .

Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.

I. Barbash, D. Dvir, K. Kent, 2012, The American journal of cardiology.

DOES MILD AORTIC REGURGITATION IN PATIENTS POST-TRANSCATHETER AORTIC VALVE REPLACEMENT IMPACT MORTALITY?

A. Pichard, L. Satler, R. Torguson, 2014 .

Real‐world clinical practice of intracoronary radiation therapy as compared to investigational trials

K. Kent, A. Pichard, L. Satler, 2005 .

Population characteristics, treatment assignment, and clinical outcome of patients with severe aortic stenosis who were not eligible to participate in a clinical trial evaluation percutaneous aortic valve replacement

K. Kent, A. Pichard, L. Satler, 2009 .

Safety and efficacy of everolimus-eluting stents versus sirolimus-eluting stents in women.

I. Barbash, D. Dvir, A. Pichard, 2013, The American journal of cardiology.

TRANSCATHETER AORTIC VALVE IMPLANTATION UNDER CONSCIOUS SEDATION VERSUS GENERAL ANESTHESIA WITH INTUBATION

K. Kent, A. Pichard, L. Satler, 2010 .

HIGH TRANSVALVULAR GRADIENT VERSUS LOW TRANSVALVULAR GRADIENT IN PATIENTS WITH SEVERE AORTIC STENOSIS AND POOR LEFT VENTRICULAR FUNCTION

K. Kent, A. Pichard, L. Satler, 2011 .

Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy.

N. Weissman, K. Kent, A. Pichard, 2004, Cardiovascular radiation medicine.

Body mass index association with survival in severe aortic stenosis patients undergoing transcatheter aortic valve replacement

A. Pichard, L. Satler, R. Torguson, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Abstract 4456: The Impact of Nuisance Bleeding on Clopidogrel Compliance in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2008 .

PERIPHERAL VASCULAR DISEASE Original Studies A Novel, Minimally Invasive Access Technique Versus Standard 18-Gauge Needle Set for Femoral Access

A. Pichard, L. Satler, R. Torguson, 2012 .

A. Pichard, R. Torguson, M. Gaglia, 2017, The American journal of cardiology.

Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation.

I. Barbash, D. Dvir, A. Pichard, 2012, The American journal of cardiology.

Management and Outcome of Residual Aortic Regurgitation After Transcatheter Aortic Valve Implantation.

A. Pichard, L. Satler, A. Steinvil, 2017, The American journal of cardiology.

Do patients with drug-eluting stent thrombosis have a similar prognosis to patients presenting with st-Elevation myocardial infarction of de novo lesions?

A. Pichard, L. Satler, R. Torguson, 2011, Journal of interventional cardiology.

Comparison of clinical outcomes with the utilization of monitored anesthesia care vs. general anesthesia in patients undergoing transcatheter aortic valve replacement.

A. Pichard, L. Satler, F. Asch, 2016, Cardiovascular revascularization medicine : including molecular interventions.

An innovative noninvasive respiratory stress test indicates significant coronary artery disease.

R. Torguson, A. Katz, S. Scharf, 2010, Cardiovascular revascularization medicine : including molecular interventions.

Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry).

I. Barbash, D. Dvir, A. Pichard, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Outcome Comparison of African-American and Caucasian Patients with Severe Aortic Stenosis Subjected to Transcatheter Aortic Valve Replacement: A Single-Center Experience

I. Barbash, A. Pichard, L. Satler, 2015 .

Impact of smoking on acute phase outcomes of myocardial infarction

K. Kent, A. Pichard, L. Satler, 2011, Coronary artery disease.

Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety.

M. Mack, E. Tuzcu, L. Svensson, 2016, The Journal of thoracic and cardiovascular surgery.

Comparison of adverse outcomes after contemporary percutaneous coronary intervention in women versus men with acute coronary syndrome.

I. Barbash, D. Dvir, A. Pichard, 2013, The American journal of cardiology.

Correlation between lipidic content and arterial-wall plaque burden: A lipid rich plaque study sub-analysis.

Brian C. Case, C. Di Mario, G. Mintz, 2022, International Journal of Cardiology.

Longitudinal Distribution of Lipid-Rich Plaque in Nonculprit Lesions: A Lipid Rich Plaque Study Subanalysis.

Z. Ali, C. Di Mario, G. Mintz, 2021, JACC Cardiovascular Imaging.

Greater plaque burden and cholesterol content may explain an increased incidence of non-culprit events in diabetic patients: a Lipid-Rich Plaque substudy.

Z. Ali, C. Di Mario, G. Mintz, 2021, European heart journal. Cardiovascular Imaging.

Frequency of Lipid-Rich Coronary Plaques in Stable Angina Pectoris versus Acute Coronary Syndrome (from the Lipid Rich Plaque Study).

Z. Ali, G. Mintz, R. Torguson, 2021, American Journal of Cardiology.

The vulnerable plaque detected: time to consider treatment

R. Torguson, R. Waksman, 2021, The Lancet.

Near-Infrared Spectroscopy Intravascular Ultrasound Imaging Evaluation in Patients With Chronic Renal Insufficiency.

C. Di Mario, G. Mintz, R. Torguson, 2021, JACC Cardiovascular Imaging.

FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study.

R. Torguson, S. Marso, N. Palmer, 2013, Journal of the American College of Cardiology.

Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.

A. Pichard, L. Satler, R. Torguson, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.

A. Pichard, L. Satler, S. Collins, 2010, Journal of interventional cardiology.

Optimal revascularization strategies for percutaneous coronary intervention of distal anastomotic lesions after coronary artery bypass surgery.

I. Barbash, D. Dvir, A. Pichard, 2013, Journal of interventional cardiology.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Choice of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Impacts Hemodynamics Differently According to Aortic Annular Size.

A. Pichard, L. Satler, A. Steinvil, 2017, The American journal of cardiology.

Overview of the virtual 2020 FDA's circulatory system devices advisory panel on Neovasc reducer system

R. Torguson, Giorgio A. Medranda, R. Waksman, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

OUTPATIENT TRENDS IN DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME AND PRIMARY PERCUTANEOUS CORONARY INTERVENTION

A. Pichard, L. Satler, A. Steinvil, 2017 .

Racial disparities in clinical characteristics and outcomes of women undergoing percutaneous coronary intervention.

W. Weintraub, R. Torguson, P. Kolm, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?

R. Torguson, C. Mackay, R. Waksman, 2015, The Lancet.

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel meeting on device-based therapies for hypertension.

W. Weintraub, R. Torguson, Nauman Khalid, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary intervention.

I. Barbash, A. Pichard, L. Satler, 2014, Cardiovascular revascularization medicine : including molecular interventions.